Sommaire

Numéro précédent | Numéro suivant

• • ·Japan’s nuclear crisis

    Page :409

     
• • ·Subcutaneous bortezomib: a step towards optimised drug use

    Page :410-411

    María-Victoria Mateos

     
• • ·Androgen deprivation before prostate radiotherapy: how long is long enough?

    Page :411-412

    Chris Parker

     
• • ·Hope for very elderly patients with diffuse large B-cell lymphoma

    Page :412-413

    Josep-Maria Ribera

     
• • ·Sentinel-node biopsy in endometrial cancer: a win–win scenario?

    Page :413-414

    Henry C Kitchener

     
• • ·Genetic variants associated with breast-cancer risk

    Page :415-416

    Steven A Narod

     
• • ·25 years after Chernobyl: lessons for Japan?

    Page :416-418

    Kirsten B Moysich, Philip McCarthy, Per Hall

     
• • ·Erratum

    Page :418

    
• • ·Adjuvant interferon: extended follow-up times needed?

    Page :419

    Fredrik B Thoren, Örjan Strannegård

     
• • ·How does TPF improve survival over PF?

    Page :419-420

    Kiran Devisetty, Stuart J Wong, Loren K Mell

    
• • ·How does TPF improve survival over PF?

    Page :420-421

    Yoann Pointreau, Ibrahim Atean, Gilles Calais

     
• • ·How does TPF improve survival over PF? – Authors’ reply

    Page :421-422

    Jochen H Lorch, Olga Goloubeva, Marshall R Posner

     
• • ·Cervical cancer: balancing obstetrical and oncological outcomes

    Page :422

    Michael Höckel, Lars-Christian Horn

    
• • ·Cervical cancer: balancing obstetrical and oncological outcomes – Authors’ reply

    Page :422-423

    Lukas Rob, Helena Robova

    
• • ·For an operational definition of cachexia

    Page :423-424

    Thierry Pepersack

     
• • ·UK Government hits the pause button over NHS reforms

    Page :425-426

    David Holmes

     
• • ·Australia to be first country to use plain cigarette packaging

    Page :427

    Tony Kirby

     
• • ·Cancer mortality in Northern Ireland

    Page :428

    Talha Burki

     
• • ·Smart phones: new clinical tools in oncology?

    Page :429-430

    Kathryn Senior

     
• • ·Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study

    Page :431-440

    Philippe Moreau, Halyna Pylypenko, Sebastian Grosicki, Ievgenii Karamanesht, Xavier Leleu, Maria Grishunina, Grigoriy Rekhtman, Zvenyslava Masliak, Tadeusz Robak, Anna Shubina, Bertrand Arnulf, Martin Kropff, James Cavet, Dixie-Lee Esseltine, Huaibao Feng, Suzette Girgis, Helgi van de Velde, William Deraedt, Jean-Luc Harousseau

    Résumé Résumé Plan Plan   
• • ·Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study

    Page :441-450

    Mariëlle Kocken, Theo JM Helmerhorst, Johannes Berkhof, Jacqueline A Louwers, Mariëlle AE Nobbenhuis, Aagje G Bais, Cornelis JA Hogewoning, Afra Zaal, René HM Verheijen, Peter JF Snijders, Chris JLM Meijer

    Résumé Résumé Plan Plan  
• • ·Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial

    Page :451-459

    James W Denham, Allison Steigler, David S Lamb, David Joseph, Sandra Turner, John Matthews, Chris Atkinson, John North, David Christie, Nigel A Spry, Keen-Hun Tai, Chris Wynne, Catherine D’Este

    Résumé Résumé Plan Plan   
• • ·Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial

    Page :460-468

    Frédéric Peyrade, Fabrice Jardin, Catherine Thieblemont, Antoine Thyss, Jean-François Emile, Sylvie Castaigne, Bertrand Coiffier, Corinne Haioun, Serge Bologna, Olivier Fitoussi, Gérard Lepeu, Christophe Fruchart, Dominique Bordessoule, Michel Blanc, Richard Delarue, Maud Janvier, Bruno Salles, Marc André, Marion Fournier, Philippe Gaulard, Hervé Tilly, for the Groupe d’Etude des Lymphomes de l’Adulte (GELA) investigators ‡

    Résumé Résumé Plan Plan   
• • ·Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO)

    Page :469-476

    Marcos Ballester, Gil Dubernard, Fabrice Lécuru, Denis Heitz, Patrice Mathevet, Henri Marret, Denis Querleu, François Golfier, Eric Leblanc, Roman Rouzier, Emile Daraï

    Résumé Résumé Plan Plan  
• • ·Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence

    Page :477-488

    Ben Zhang, Alicia Beeghly-Fadiel, Jirong Long, Wei Zheng

    Résumé Résumé Plan Plan   
• • ·Definition and classification of cancer cachexia: an international consensus

    Page :489-495

    Kenneth Fearon, Florian Strasser, Stefan D Anker, Ingvar Bosaeus, Eduardo Bruera, Robin L Fainsinger, Aminah Jatoi, Charles Loprinzi, Neil MacDonald, Giovanni Mantovani, Mellar Davis, Maurizio Muscaritoli, Faith Ottery, Lukas Radbruch, Paula Ravasco, Declan Walsh, Andrew Wilcock, Stein Kaasa, Vickie E Baracos

    Résumé Résumé Plan Plan  
• • ·Preventive therapy for breast cancer: a consensus statement

    Page :496-503

    Jack Cuzick, Andrea DeCensi, Banu Arun, Powel H Brown, Monica Castiglione, Barbara Dunn, John F Forbes, Agnes Glaus, Anthony Howell, Gunter von Minckwitz, Victor Vogel, Heinz Zwierzina

    Résumé Résumé Plan Plan  
• • ·Microbial and viral pathogens in colorectal cancer

    Page :504-512

    Danielle Collins, Aisling M Hogan, Desmond C Winter

    Résumé Résumé Plan Plan